Brazzaville- August 2024- As the mpox outbreak that has affected the Democratic Republic of the Congo and spread to neighbouring countries continues to grow, World Health Organization (WHO) is intensifying support to countries to scale up measures to curb the virus and save lives.
On the advice of independent experts of the International Health Regulations Emergency Committee, WHO Director-General has determined that the upsurge of mpox constitutes a public health emergency of international concern (PHEIC). The emergence of a new strain of the mpox virus in the Democratic Republic of the Congo and its rapid spread, including to neighbouring countries, is one of the main reasons for the declaration of the PHEIC, the second such determination in two years relating to the disease.
So far this year, more than 2100 laboratory-confirmed cases and 13 deaths have been reported from 12 countries (Burundi, Cameroon, Central African Republic, Congo, Cote d’Ivoire, the Democratic Republic of the Congo, Kenya, Liberia, Nigeria, Rwanda, South Africa and Uganda) compared with 1145 confirmed cases and seven deaths in the whole of 2023 reported from 11 countries.
“We are hard at work on the frontlines of the response, collaborating closely with governments and communities to strengthen mpox control measures and are ramping up efforts to curb the widening trend of the virus through coordinated action with partners and national authorities,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.
WHO is stepping up support to the affected countries by deploying additional experts, including epidemiologists and anthropologists, and providing initial funding to accelerate outbreak response measures. Efforts are underway to enhance cross-border collaboration for case investigation, contact tracing and community engagement to ensure compliance with preventive measures.
Also Read: Mpox poses growing threat to public health across Africa
The Organization is also supporting national regulatory authorities to speed up regulatory approvals, as well as providing guidance to national immunization technical advisory groups to ensure readiness for vaccine rollout. However, WHO has triggered the process for Emergency Use Listing for mpox vaccines, which will accelerate vaccine access for lower-income countries which have not yet issued their own national regulatory approval. Emergency Use Listing enables partners including Gavi, the Vaccine Alliance, and UNICEF to procure vaccines for distribution.
Caused by an Orthopoxvirus, mpox was first detected in humans in 1970, in the Democratic Republic of the Congo. Mpox is endemic to countries in central and West Africa. Animals transmit the disease to humans. It can also spread from human to humans through contact with bodily fluids, lesions on the skin or internal mucosal surfaces, such as in the mouth or throat, respiratory droplets and contaminated objects.
